| Trial ID: | L4486 |
| Source ID: | NCT00942318
|
| Associated Drug: |
Detemir Insulin, Aspart Insulin, Metformin
|
| Title: |
Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Detemir insulin, Aspart insulin, Metformin
|
| Outcome Measures: |
Primary: HbA1c, 12 months | Secondary: Weight, waist perimeter, BP, triglycerides, total cholesterol, HDL and LDL cholesterol ; QOL, physical activity, treatment satisfaction and eating habits questionnaire., 12 months|self monitoring blood glucose measurements (frequency, mean and standard deviation, number of hypoglycaemic and hyperglycaemic events), 12 months
|
| Sponsor/Collaborators: |
Sponsor: University Hospital, Toulouse
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
52
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
2013-02
|
| Results First Posted: |
|
| Last Update Posted: |
2013-12-11
|
| Locations: |
University Hospital Toulouse, Toulouse, 31059, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00942318
|
